Safety begins before scheduling

The first step is a clinical evaluation, not a treatment slot. The care team reviews diagnosis, previous treatments, medical history, medications, implanted or metallic devices, seizure-related risks, and other factors identified in the device labeling and clinic protocol. Uncertain cases should be escalated to the responsible clinician before treatment begins.

Consent should prepare the patient for the actual experience

Patients need a plain explanation of the treatment plan, expected sensations, common side effects, uncommon but serious risks, alternatives, session schedule, and whom to contact with concerns. Consent is stronger when the patient has time to ask questions and understands that response cannot be guaranteed.

Every session needs a reliable check

The clinic should confirm relevant changes in health, medication, sleep, substance use, symptoms, and safety concerns. Staff also verify the patient, device settings, treatment plan, and coil position according to protocol. Small checks reduce the chance that important changes remain invisible across a multiweek course.

Outcome monitoring creates an early warning system

Structured symptom measures help the clinician see whether the patient is improving, unchanged, or worsening. Scores should support, not replace, a clinical conversation. Suicidal thoughts, emerging mania, neurological symptoms, or other urgent concerns require a defined response rather than a routine note in the record.

The handoff after treatment matters

At the end of a course, the patient and referring provider should receive a clear summary of treatment delivered, response, next steps, and follow-up plan. Safety is a continuous process that extends beyond the device room.